Dietary marigold-derived lutein produces dose- and time-dependent egg yolk enrichment and coordinated hepatic–ovarian responses in laying hens Authors: Shan Gao, Uchechukwu Edna Obianwuna, Wenke Tao, Kai Qiu, Jing Wang, Haijun Zhang, Guanghai Qi, Jianmin Zhou, Shugeng Wu Published: 2026 ABSTRACT Marigold-derived lutein is widely used to enhance egg yolk pigmentation, but its dose-dependent deposition efficiency, temporal accumulation, post-withdrawal clearance, and associated hepatic–ovarian responses remain incompletely defined. This study evaluated these responses in 450 23-wk-old Jingfen No. 6 laying hens assigned to diets containing 0, 40, 80, 120, or 160 mg/kg marigold-derived lutein for 12 wk, with 6 replicates of 15 hens per treatment. Dietary lutein did not affect overall laying performance or conventional egg-quality traits (P > 0.05). Yolk color increased rapidly in a dose-responsive manner from D3 of supplementation and remained elevated through D28 (P < 0.001). At D21, egg lutein content increased with supplementation level (P < 0.001), whereas incremental apparent deposition efficiency declined from 8.42% at 40 mg/kg to 5.28% at 160 mg/kg (P = 0.016). After withdrawal, egg lutein content remained relatively stable during the first 3 d, declined sharply between WD3 and WD7, and no longer differed among groups by WD10. Exploratory analyses comparing the 0 and 120 mg/kg groups showed that hens fed 120 mg/kg lutein had lower serum total cholesterol, LDL-C, VLDL, and MTTP and higher vitellogenin, estradiol, luteinizing hormone, and follicle-stimulating hormone (P < 0.05). It also decreased hepatic BCO2, PPARγ, and apoVLDL-II expression, while increasing hepatic ERα and ApoA1 and ovarian VLDLR, ApoA1, and ERα expression (P < 0.05). Serum estradiol was positively correlated with ovarian ERα and ApoA1, and serum vitellogenin was positively correlated with ovarian VLDLR. These findings show that marigold-derived lutein rapidly enriches egg yolk, but incremental apparent deposition efficiency declines at higher dietary inclusion levels. Continuous supplementation was required to maintain enrichment, and the serum and transcriptional responses observed at 120 mg/kg were consistent with reduced hepatic carotenoid cleavage, altered circulating endocrine and lipid-related status, and greater ovarian yolk-precursor uptake capacity, which may jointly favor lutein deposition in egg yolk. Introduction The nutritional modification of table eggs is an established strategy for delivering lipophilic bioactive compounds through a widely consumed food matrix. Among these compounds, lutein is a dihydroxy xanthophyll valued both as a natural pigment and as a dietary constituent associated with visual and systemic antioxidant functions. Poultry cannot synthesize carotenoids de novo; consequently, yolk carotenoid concentration and pigmentation depend largely on the amount, chemical form, dietary matrix, and bioavailability of carotenoids supplied in the feed (Dansou et al., 2023; Miao et al., 2024). Marigold (Tagetes erecta) extract is particularly rich in lutein esters and is therefore widely used to increase yolk pigmentation and produce lutein-enriched eggs. Egg yolk is an effective carrier of lutein because the carotenoid is incorporated into a lipid-rich matrix. Human studies have shown that lutein from enriched eggs can be highly bioavailable, supporting the use of eggs as functional-food vehicles for dietary lutein delivery (Chung et al., 2004). In laying hens, supplementation with lutein or marigold-derived carotenoids consistently increases yolk pigmentation and lutein concentration. However, the increase in yolk lutein is not always directly proportional to the dietary inclusion level (Grčević et al., 2019; Leeson and Caston, 2004; Skřivan et al., 2015). Higher inclusion levels may increase absolute yolk enrichment while reducing the additional deposition achieved per unit of lutein supplied. Accordingly, both egg lutein content and incremental apparent deposition efficiency should be considered when evaluating supplementation responses. The transfer of dietary lutein into egg yolk involves several sequential physiological processes. Following release from the feed matrix, lutein is incorporated into mixed micelles during lipid digestion, absorbed by the intestine, and transported in circulating lipoproteins. Its subsequent deposition depends on hepatic metabolism, lipoprotein packaging, systemic transport, and receptor-mediated uptake by developing ovarian follicles (Dansou et al., 2023; Papadopoulos et al., 2019). Variation at any of these stages may influence the amount of lutein ultimately deposited in the yolk. The liver–blood–ovary axis provides the principal physiological route for transporting yolk lipids and associated lipophilic compounds in laying hens. Under estrogenic regulation, the liver synthesizes and secretes yolk precursors, including vitellogenins and a specialized yolk-targeted form of very-low-density lipoprotein, VLDLy. Estrogen induces the hepatic assembly of these smaller, triglyceride-rich VLDLy particles, which are adapted for transport to and uptake by developing ovarian follicles (Walzem et al., 1999). Circulating VLDLy and vitellogenin are subsequently internalized by growing oocytes through receptor-mediated endocytosis, with VLDLR playing a central role in yolk-precursor uptake (Bujo et al., 1994; Schneider, 2016). Estrogen receptor alpha (ERα) is a major mediator of estrogen-responsive hepatic transcription during yolk formation, while apolipoproteins and lipid receptors influence lipoprotein assembly, transport, and ovarian uptake (Li et al., 2014; Ren et al., 2021; Song et al., 2023). Therefore, lutein deposition may depend not only on dietary availability but also on its metabolic preservation and distribution among circulating yolk-precursor and lipoprotein pathways. Carotenoid cleavage may further regulate the quantity of intact lutein available for tissue deposition. Beta-carotene oxygenase 2 (BCO2) is a mitochondrial carotenoid-cleaving enzyme capable of degrading xanthophylls. Genetic and physiological evidence in chickens indicates that reduced BCO2 activity or expression is associated with increased carotenoid retention and pigmentation (Wang et al., 2023). Consequently, variation in hepatic BCO2 expression may alter the amount of dietary lutein available for incorporation into circulating lipoproteins and subsequent deposition in the yolk. Previous dose-response studies have tested widely different lutein levels and sources, which may partly account for the variable responses reported in laying hens. Lokaewmanee et al. (2011) showed that yolk pigmentation was affected by both lutein level and source when hens were fed 0–40 mg/kg lutein from marigold meal or extract. In studies using much higher inclusion levels, Leeson and Caston (2004) reported diminishing pigmentation responses at up to 1,000 mg/kg lutein, whereas Leeson et al. (2007) found that 125 or 250 mg/kg lutein improved yolk color and egg lutein content during long-term supplementation, although early egg production was reduced at 250 mg/kg. These studies indicate that yolk lutein deposition depends not only on dietary dose, but also on lutein source, formulation, and supplementation duration. However, the dynamics of yolk lutein deposition remain less clearly defined, as many studies have relied on terminal measurements rather than tracking accumulation during supplementation and clearance after withdrawal. Moreover, limited work has examined these deposition kinetics alongside serum lipid and reproductive indices and selected hepatic–ovarian genes related to lipid transport, estrogen signaling, and yolk-precursor uptake within the same experimental framework. The present study, therefore, evaluated the effects of graded dietary marigold lutein supplementation on laying performance, egg quality, yolk color, and yolk lutein deposition in laying hens, with particular attention to dose-related enrichment, incremental apparent deposition efficiency, and the accumulation and clearance of lutein in egg yolk. To provide a preliminary physiological context for these responses, serum lipid and reproductive indices, together with selected hepatic and ovarian genes related to lipid transport, estrogen signaling, and yolk-precursor uptake, were also examined. We hypothesized that dietary lutein would enrich egg yolk in a dose- and time-dependent manner, while incremental apparent deposition efficiency would decline at higher inclusion levels, and that these responses would be associated with changes in hepatic–ovarian lipid transport and estrogen-responsive pathways. Materials and methods Ethic statement All animal procedures were conducted according to institutional guidelines and applicable national standards. The experimental protocol was approved by the Animal Care and Use Committee of the Institute of Feed Research, Chinese Academy of Agricultural Sciences (approval No. AEC-CAAS-20250611). Experimental design and egg collection A total of 450 23-wk-old Jingfen No. 6 commercial laying hens with an initial laying rate above 90% were fed a corn–soybean meal basal diet during a 1-wk adaptation period. The hens were then assigned to five dietary treatments in a completely randomized design, with 6 replicates of 15 hens per treatment. Hens were housed 3 per cage in three-tier conventional cages, and 5 adjacent cages constituted one replicate. The basal diet was formulated according to the Chinese Feeding Standard of Chickens (NY/T 33-2004), and its composition and nutrient levels are shown in Table 1. The marigold-derived lutein product contained a manufacturer-declared minimum of 20 g active lutein/kg (batch No. 25040901; Guangzhou Leader Biotechnology Co., Ltd., Guangzhou, China). It was added to the basal diet at 0, 2, 4, 6, or 8 kg/t, corresponding to nominal supplemental levels of 0, 40, 80, 120, or 160 mg active lutein/kg, respectively. Lutein concentrations were not analytically determined in either the basal or complete experimental diets. The 12-wk supplementation period ended with egg collection immediately before supplemental lutein withdrawal (WD0), followed by 10 d of post-withdrawal clearance during which all hens received the basal diet without supplemental lutein. Feed and water were provided ad libitum throughout the experiment. Hens were maintained under a 16-h light:8-h dark photoperiod at an ambient temperature of 22 to 24°C and relative humidity of 60 to 70%.Table 1Composition and nutrient levels of the basal diet (air-dry basis)a.IngredientContent (%)Nutrient levelscValue (%)Corn62.68Metabolizable energy (MJ/kg)11.30Soybean meal24.13Crude protein16.46Wheat bran2.00Calcium3.52Soybean oil0.65Total phosphorus0.49Limestone9.00Nonphytate phosphorus0.36DL-Methionine (99%)0.16Methionine0.34Dicalcium phosphate0.85Methionine + cysteine0.62Sodium chloride0.32Lysine0.73Premixb0.13Threonine0.51Choline chloride0.05Phytase0.03Total100.00aThe marigold-derived lutein product contained a manufacturer-declared minimum of 20 g active lutein/kg and was added to the basal diet at 0, 2, 4, 6, or 8 kg/t, corresponding to nominal supplemental levels of 0, 40, 80, 120, or 160 mg active lutein/kg, respectively. Lutein concentrations in the basal and complete experimental diets were not analytically determined.bPremix provided per kg of diet: VA, 12,500 IU; VD₃, 4,125 IU; VE, 15 IU; VK, 2 mg; VB₁, 1 mg; VB₂, 8.5 mg; VB₆, 8 mg; VB₁₂, 5 μg; pantothenic acid, 50 mg; niacin, 32.5 mg; biotin, 2 mg; folic acid, 5 mg; choline, 500 mg; Mn, 65 mg; I, 1 mg; Fe, 60 mg; Cu, 8 mg; Zn, 66 mg.cCrude protein, calcium, and total phosphorus were analyzed; the remaining nutrient values were calculated. Table 1Composition and nutrient levels of the basal diet (air-dry basis)a.IngredientContent (%)Nutrient levelscValue (%)Corn62.68Metabolizable energy (MJ/kg)11.30Soybean meal24.13Crude protein16.46Wheat bran2.00Calcium3.52Soybean oil0.65Total phosphorus0.49Limestone9.00Nonphytate phosphorus0.36DL-Methionine (99%)0.16Methionine0.34Dicalcium phosphate0.85Methionine + cysteine0.62Sodium chloride0.32Lysine0.73Premixb0.13Threonine0.51Choline chloride0.05Phytase0.03Total100.00aThe marigold-derived lutein product contained a manufacturer-declared minimum of 20 g active lutein/kg and was added to the basal diet at 0, 2, 4, 6, or 8 kg/t, corresponding to nominal supplemental levels of 0, 40, 80, 120, or 160 mg active lutein/kg, respectively. Lutein concentrations in the basal and complete experimental diets were not analytically determined.bPremix provided per kg of diet: VA, 12,500 IU; VD₃, 4,125 IU; VE, 15 IU; VK, 2 mg; VB₁, 1 mg; VB₂, 8.5 mg; VB₆, 8 mg; VB₁₂, 5 μg; pantothenic acid, 50 mg; niacin, 32.5 mg; biotin, 2 mg; folic acid, 5 mg; choline, 500 mg; Mn, 65 mg; I, 1 mg; Fe, 60 mg; Cu, 8 mg; Zn, 66 mg.cCrude protein, calcium, and total phosphorus were analyzed; the remaining nutrient values were calculated. Composition and nutrient levels of the basal diet (air-dry basis)a. The marigold-derived lutein product contained a manufacturer-declared minimum of 20 g active lutein/kg and was added to the basal diet at 0, 2, 4, 6, or 8 kg/t, corresponding to nominal supplemental levels of 0, 40, 80, 120, or 160 mg active lutein/kg, respectively. Lutein concentrations in the basal and complete experimental diets were not analytically determined. Premix provided per kg of diet: VA, 12,500 IU; VD₃, 4,125 IU; VE, 15 IU; VK, 2 mg; VB₁, 1 mg; VB₂, 8.5 mg; VB₆, 8 mg; VB₁₂, 5 μg; pantothenic acid, 50 mg; niacin, 32.5 mg; biotin, 2 mg; folic acid, 5 mg; choline, 500 mg; Mn, 65 mg; I, 1 mg; Fe, 60 mg; Cu, 8 mg; Zn, 66 mg. Crude protein, calcium, and total phosphorus were analyzed; the remaining nutrient values were calculated. Egg quality measurements At the end of wk 4, 8, and 12, 6 eggs per replicate were collected for egg quality determination. Eggs with abnormal shape, visible shell defects, cracks, or obvious contamination were excluded. All eggs were collected immediately after laying and analyzed within 4 h after collection. Egg weight was measured using a digital balance. Egg length and width were measured, and egg shape index was calculated as egg length divided by egg width. Eggshell strength was measured using an Egg Force Reader (ORKA Food Technology Ltd., Ramat HaSharon, Israel). Eggshell thickness was measured at the air cell, equator, and sharp end using an Eggshell Thickness Gauge (ORKA Food Technology Ltd.), and the mean of the three measurements was used for statistical analysis. After breakout, albumen height, Haugh unit, and yolk color score were determined using an automated Egg Analyzer (ORKA Food Technology Ltd.). Yolk color during lutein deposition and post-withdrawal clearance During the deposition phase, yolk color score was determined on D3, D7, D10, D14, D21, and D28 after the initiation of dietary lutein supplementation. Yolk color score was also determined at WD0, WD3, WD7, and WD10. During the post-withdrawal phase, yolk color was also measured instrumentally using the CIE L*, a*, and b* system with a colorimeter (NH300, Shenzhen 3nh Technology Co., Ltd., Shenzhen, China). The colorimeter was calibrated before use according to the manufacturer’s instructions. L*, a*, and b* values represented lightness, redness, and yellowness, respectively. Measurements were taken directly on the surface of the intact yolk immediately after breakout. Yolk lutein content and incremental apparent deposition efficiency Yolk lutein content was measured in all five groups at D21 for dose-response analysis, and in the 0, 40, and 120 mg/kg groups at D3, D7, D10, D14, D21, WD0, WD3, WD7, and WD10 for dynamic deposition and clearance analyses. Yolk lutein concentration was determined by high-performance liquid chromatography with diode-array detection (HPLC-DAD) according to the method of Schlatterer and Breithaupt (2006), with minor modifications. Briefly, approximately 1.0 g of homogenized yolk was extracted with acetone containing 0.05% butylated hydroxytoluene under light-protected conditions. The mixture was vortexed and centrifuged, and extraction was repeated until the residue became nearly colorless. The combined extracts were evaporated to dryness under nitrogen and reconstituted in the mobile phase. The reconstituted extract was filtered through a 0.22-μm organic-phase membrane filter and analyzed using an Agilent 1260 Infinity II HPLC system equipped with a diode-array detector (Agilent Technologies, Santa Clara, CA, USA). Lutein was separated on a C30 reversed-phase column and detected at 450 nm. Identification was based on the retention time of an authentic lutein standard, and quantification was performed using an external standard calibration curve. The lutein analytical standard (product No. 07168; Sigma-Aldrich, St. Louis, MO, USA) had an assay of ≥96.0% by HPLC. Calibration was linear over 0.05–30.0 μg/mL (R2 = 0.999). Mean extraction recovery from yolk samples spiked at three concentration levels was 95.0%, and repeatability RSDs were below 5.0% across these levels. The limits of detection and quantification were 0.0096 and 0.0340 μg/mL, respectively, based on signal-to-noise ratios of 3 and 10. Lutein content in the edible egg portion was calculated from yolk lutein concentration, yolk weight, and edible egg weight, and expressed as μg/100 g edible portion. Incremental apparent lutein deposition efficiency was calculated for each supplemented replicate as follows: Incremental apparent lutein deposition efficiency (%) = [(daily egg lutein output − time-matched mean control egg lutein output) / daily supplemental lutein intake] × 100. Daily egg lutein output was calculated from yolk lutein concentration, yolk weight, and HDEP, and daily supplemental lutein intake from ADFI and the supplementation level. The 0 mg/kg group served as the background reference and was not assigned an efficiency value because no supplemental lutein was provided. Lutein retention rate during the post-withdrawal phase was calculated as follows: Lutein retention rate (%) = [yolk lutein content at each post-withdrawal time point / yolk lutein content at WD0] × 100. Blood and tissue collection Based on the yolk lutein dose-response results, the 120 mg/kg treatment was selected as a representative high-enrichment level for targeted serum and transcriptional analyses. At the end of the 12-wk feeding period and before lutein withdrawal, one representative hen with body weight and laying performance close to the replicate mean was selected from each replicate of the 0 and 120 mg/kg groups, giving 6 hens per treatment. Blood and tissue samples were collected within the same time window to reduce variation associated with feeding and reproductive rhythms. The selected hens were euthanized by exsanguination through the jugular vein. Approximately 5 mL of blood was collected from each hen into serum collection tubes. Blood samples were allowed to clot at room temperature and then centrifuged at 3,000 × g for 15 min. Serum was stored at −20°C until biochemical, yolk-precursor, and reproductive-hormone analyses. After blood collection, liver and ovarian tissues were collected, snap-frozen in liquid nitrogen, and stored at −80°C. Serum lipid-related indices, vitellogenin, and reproductive hormones Serum total cholesterol (TC; ml076635), triglyceride (TG; ml076637), high-density lipoprotein cholesterol (HDL-C; ml036973), low-density lipoprotein cholesterol (LDL-C; ml036983), and very-low-density lipoprotein (VLDL; ml060950) were measured using colorimetric assay kits from Shanghai Enzyme-linked Biotechnology Co., Ltd. (Shanghai, China). Serum vitellogenin (VTG; YJ025401), estradiol (E2; YJ023194), luteinizing hormone (LH; YJ611689), and follicle-stimulating hormone (FSH; YJ042764) were quantified using ELISA kits from the same supplier. Serum microsomal triglyceride transfer protein large subunit (MTTP) was measured using a chicken-specific ELISA kit (LM8K200CK; Shanghai Lianmai Bioengineering Co., Ltd., Shanghai, China). Absorbance was measured using a microplate reader for all assays, with ELISA plates read at 450 nm. All assays were performed according to the manufacturers’ instructions. Samples were analyzed in duplicate, and the mean of the two determinations was used for statistical analysis. RNA isolation and real-time quantitative PCR Total RNA was extracted from liver and ovarian samples using the EasyPure RNA kit (TransGen Biotech Co., Ltd., Beijing, China), and RNA concentration was determined with an Epoch Microplate Spectrophotometer (BioTek Instruments, Inc., VT, USA). Reverse transcription was performed using the First-Strand cDNA Synthesis SuperMix (TransGen Biotech Co., Ltd., Beijing, China). Quantitative PCR was conducted in triplicate on a CFX96 real-time PCR system (Bio-Rad Laboratories, CA, USA). Relative mRNA expression was determined for hepatic genes involved in carotenoid cleavage, lipid metabolism, estrogen signaling, and yolk-precursor synthesis, including beta-carotene oxygenase 2 (BCO2), peroxisome proliferator-activated receptor alpha (PPARα), peroxisome proliferator-activated receptor gamma (PPARγ), apolipoprotein very low-density lipoprotein II (apoVLDL-II), microsomal triglyceride transfer protein (MTTP), estrogen receptor alpha (ERα), estrogen receptor beta (ERβ), apolipoprotein A1 (ApoA1), and vitellogenin II (VTG-II). Ovarian genes related to lipid and yolk-precursor uptake and estrogen signaling were also analyzed, including very low-density lipoprotein receptor (VLDLR), scavenger receptor class B type I (SR-BI), cluster of differentiation 36 (CD36), VTG-II, ApoA1, ERα, and ERβ. Relative mRNA expression was calculated using the 2−ΔΔCt method (Livak and Schmittgen, 2001), normalized to GAPDH; primer sequences are listed in Table 2.Table 2Primer sequences used for quantitative real-time PCR (qRT-PCR).GenePrimer sequence (5′→3′)Length (bp)Accession No.BCO2F: CCAAGGCTGAAGGAACCACTR: TGGAGCTTCCCTCTTCCTCA98XM_417929.8apoVLDL-IIF: CCTTAGCACCACTGTCCCTGR: AGCTCTAGGGGACACCTTGT130NM_205483.2MTTPF: GTTCTGAAGGACATGCGTGCR: GATGTCTAGGCCGTACGTGG120NM_001109784.2PPARαF: AGGCCAAGTTGAAAGCAGAAR: TTTCCCTGCAAGGATGACTC155NM_001001464.1PPARγF: TGACAGGAAAGACGACAGACAR: CTCCACAGAGCGAAACTGAC164NM_001001460.1ApoA1F: TCCTTCTGGCAGCACGATGR: CCACAGCAGAGGACTCGAAC127NM_205525.5VTG-IIF: AACTACTCGATGCCCGCAAAR: ACCAGCAGTTTCACCTGTCC179NM_001031276.1ERαF: TGTGCTGTGTGCAACGACTAR: CAGGCCTGGCAACTCTTTCT167NM_205183.2ERβF: GGCTGCAACCCGTGTAAAAGR: GCCCAGCCAATCATGTGAAC189NM_204794.2SR-BIF: ACAGGCATCCCCATGAACTGR: ATGGGATCAGCACCAGGTTG184XM_015275627.4CD36F: TGCAAAGCAGGAGGGTGAAAR: GGTGCAAAGGCCACAAAGAG94NM_001030731.1VLDLRF: CCGTTTGTATTGGCTTGATTCR: CACCATAGACTGCCTCGTTC173NM_205229.2GAPDHF: TCCTCCACCTTTGATGCGR: GTGCCTGGCTCACTCCTT144NM_204305.1Abbreviations: BCO2, beta-carotene oxygenase 2; apoVLDL-II, apolipoprotein very low-density lipoprotein II; MTTP, microsomal triglyceride transfer protein; PPARα/γ, peroxisome proliferator-activated receptor alpha/gamma; ApoA1, apolipoprotein A1; VTG-II, vitellogenin II; ERα/β, estrogen receptor alpha/beta; SR-BI, scavenger receptor class B type I; CD36, cluster of differentiation 36; VLDLR, very low-density lipoprotein receptor; GAPDH, glyceraldehyde-3-phosphate dehydrogenase (reference gene). Table 2Primer sequences used for quantitative real-time PCR (qRT-PCR).GenePrimer sequence (5′→3′)Length (bp)Accession No.BCO2F: CCAAGGCTGAAGGAACCACTR: TGGAGCTTCCCTCTTCCTCA98XM_417929.8apoVLDL-IIF: CCTTAGCACCACTGTCCCTGR: AGCTCTAGGGGACACCTTGT130NM_205483.2MTTPF: GTTCTGAAGGACATGCGTGCR: GATGTCTAGGCCGTACGTGG120NM_001109784.2PPARαF: AGGCCAAGTTGAAAGCAGAAR: TTTCCCTGCAAGGATGACTC155NM_001001464.1PPARγF: TGACAGGAAAGACGACAGACAR: CTCCACAGAGCGAAACTGAC164NM_001001460.1ApoA1F: TCCTTCTGGCAGCACGATGR: CCACAGCAGAGGACTCGAAC127NM_205525.5VTG-IIF: AACTACTCGATGCCCGCAAAR: ACCAGCAGTTTCACCTGTCC179NM_001031276.1ERαF: TGTGCTGTGTGCAACGACTAR: CAGGCCTGGCAACTCTTTCT167NM_205183.2ERβF: GGCTGCAACCCGTGTAAAAGR: GCCCAGCCAATCATGTGAAC189NM_204794.2SR-BIF: ACAGGCATCCCCATGAACTGR: ATGGGATCAGCACCAGGTTG184XM_015275627.4CD36F: TGCAAAGCAGGAGGGTGAAAR: GGTGCAAAGGCCACAAAGAG94NM_001030731.1VLDLRF: CCGTTTGTATTGGCTTGATTCR: CACCATAGACTGCCTCGTTC173NM_205229.2GAPDHF: TCCTCCACCTTTGATGCGR: GTGCCTGGCTCACTCCTT144NM_204305.1Abbreviations: BCO2, beta-carotene oxygenase 2; apoVLDL-II, apolipoprotein very low-density lipoprotein II; MTTP, microsomal triglyceride transfer protein; PPARα/γ, peroxisome proliferator-activated receptor alpha/gamma; ApoA1, apolipoprotein A1; VTG-II, vitellogenin II; ERα/β, estrogen receptor alpha/beta; SR-BI, scavenger receptor class B type I; CD36, cluster of differentiation 36; VLDLR, very low-density lipoprotein receptor; GAPDH, glyceraldehyde-3-phosphate dehydrogenase (reference gene). Primer sequences used for quantitative real-time PCR (qRT-PCR). Abbreviations: BCO2, beta-carotene oxygenase 2; apoVLDL-II, apolipoprotein very low-density lipoprotein II; MTTP, microsomal triglyceride transfer protein; PPARα/γ, peroxisome proliferator-activated receptor alpha/gamma; ApoA1, apolipoprotein A1; VTG-II, vitellogenin II; ERα/β, estrogen receptor alpha/beta; SR-BI, scavenger receptor class B type I; CD36, cluster of differentiation 36; VLDLR, very low-density lipoprotein receptor; GAPDH, glyceraldehyde-3-phosphate dehydrogenase (reference gene). Statistical analysis All data were analyzed using SAS 9.4 (SAS Institute Inc., Cary, NC, USA). The replicate was used as the experimental unit for laying performance, egg quality, yolk color, yolk lutein content, and incremental apparent lutein deposition efficiency; for serum and gene-expression variables, one hen selected from each replicate was used. Data from the five dietary treatments were analyzed by one-way ANOVA, and orthogonal polynomial contrasts were used to evaluate linear and quadratic responses to increasing dietary lutein levels. Temporal changes in egg lutein content, incremental apparent lutein deposition efficiency, and post-withdrawal retention were analyzed by repeated-measures ANOVA using the GLM procedure. Treatment was the between-subject factor, time was the within-subject factor, and replicate nested within treatment was the subject on which repeated measurements were made. Sphericity was assessed for the within-subject effects, and Greenhouse–Geisser-adjusted P values were reported when this assumption was violated. For lutein retention rate, WD0 was retained as the descriptive reference value but excluded from the repeated-measures analysis because it was fixed at 100% by definition. Serum indices and gene-expression data from the 0 and 120 mg/kg groups were compared using Student’s t-test. Pearson correlation analysis was performed to evaluate associations between selected serum indices and hepatic or ovarian gene expression. The serum, gene-expression, and correlation analyses were exploratory; no adjustment was applied for multiple comparisons, and the reported P values are therefore nominal. Differences were considered significant at P < 0.05. Results are presented as means with pooled SEM. Results Laying performance The effects of dietary marigold lutein supplementation on laying performance are presented in Table 3. Dietary lutein supplementation did not affect AEW, ADFI, or FCR during any period, nor did it affect HDEP during wk 1–4, wk 5–8, or the overall 12-wk period (P > 0.05). During wk 9–12, HDEP showed a significant linear increase with increasing lutein level (P = 0.022), although the overall treatment effect was not significant (P = 0.153).Table 3Effects of dietary marigold lutein supplementation on laying performance of hensa.ItembPeriod (wk)Lutein supplementation level (mg/kg)SEMP-value04080120160ANOVALinearQuadraticHDEP (%)1–495.3295.0894.0594.4495.560.6810.9620.9740.7815–890.8893.2192.2693.6992.500.4450.3370.2440.2339–1278.5281.1181.2881.2582.490.5080.1530.0220.0571–1288.2089.7589.2089.8090.180.4350.6720.1970.420AEW (g)1–452.4952.5252.6152.3452.020.1220.6070.1990.2615–852.3852.7352.3652.3152.230.1640.9070.5410.7739–1252.7852.5252.6152.3452.020.1950.8040.2260.4681–1252.5752.5952.5452.3452.100.1370.7820.2190.405ADFI (g/d)1–4105.63103.48101.96102.94102.380.6160.3780.1070.1475–8102.2699.9997.6199.7397.250.7610.2260.0540.1319–12107.30105.15105.29105.94104.040.9960.9020.4270.7291–12103.68101.3699.83100.8699.660.6310.2710.0540.104FCR1–42.112.082.062.092.060.0160.8650.4090.6525–82.101.981.981.971.960.0230.2580.0620.1019–122.122.072.062.082.060.0160.7930.3370.5491–122.122.052.042.052.030.0170.5310.1590.271an = 6 replicates per treatment (15 birds per replicate).bHDEP, hen-day egg production; AEW, average egg weight; ADFI, average daily feed intake; FCR, feed conversion ratio (g feed/g egg mass). Table 3Effects of dietary marigold lutein supplementation on laying performance of hensa.ItembPeriod (wk)Lutein supplementation level (mg/kg)SEMP-value04080120160ANOVALinearQuadraticHDEP (%)1–495.3295.0894.0594.4495.560.6810.9620.9740.7815–890.8893.2192.2693.6992.500.4450.3370.2440.2339–1278.5281.1181.2881.2582.490.5080.1530.0220.0571–1288.2089.7589.2089.8090.180.4350.6720.1970.420AEW (g)1–452.4952.5252.6152.3452.020.1220.6070.1990.2615–852.3852.7352.3652.3152.230.1640.9070.5410.7739–1252.7852.5252.6152.3452.020.1950.8040.2260.4681–1252.5752.5952.5452.3452.100.1370.7820.2190.405ADFI (g/d)1–4105.63103.48101.96102.94102.380.6160.3780.1070.1475–8102.2699.9997.6199.7397.250.7610.2260.0540.1319–12107.30105.15105.29105.94104.040.9960.9020.4270.7291–12103.68101.3699.83100.8699.660.6310.2710.0540.104FCR1–42.112.082.062.092.060.0160.8650.4090.6525–82.101.981.981.971.960.0230.2580.0620.1019–122.122.072.062.082.060.0160.7930.3370.5491–122.122.052.042.052.030.0170.5310.1590.271an = 6 replicates per treatment (15 birds per replicate).bHDEP, hen-day egg production; AEW, average egg weight; ADFI, average daily feed intake; FCR, feed conversion ratio (g feed/g egg mass). Effects of dietary marigold lutein supplementation on laying performance of hensa. n = 6 replicates per treatment (15 birds per replicate). HDEP, hen-day egg production; AEW, average egg weight; ADFI, average daily feed intake; FCR, feed conversion ratio (g feed/g egg mass). Conventional egg-quality traits The effects of dietary marigold lutein on conventional egg-quality traits are shown in Table 4. Dietary treatment did not significantly affect egg shape index, eggshell breaking strength, eggshell thickness, albumen height, or Haugh unit at weeks 4, 8, or 12 (P > 0.05).Table 4Effects of dietary marigold lutein supplementation on egg quality (excluding yolk color) of laying hensa.ItemPeriod (wk)Lutein supplementation level (mg/kg)SEMP-value04080120160ANOVALinearQuadraticEgg shape index41.321.321.321.321.320.0020.8920.3220.61781.311.321.341.331.350.0070.5980.1700.369121.311.321.321.331.320.0030.3070.0970.093Eggshell strength (N)440.2539.8539.6539.6139.940.3970.9890.7650.855834.7736.7336.6337.0536.990.5040.6160.1850.2981232.9532.7432.8633.3633.540.3050.9210.4100.651Eggshell thickness (μm)4409.53408.44410.89410.07410.640.7900.8910.5010.8018397.76395.60399.84402.40390.032.2130.4860.5900.43612398.99384.22402.70401.20400.062.6210.1540.3110.573Albumen height (mm)46.156.596.286.216.250.0570.1160.7100.50086.026.576.266.276.350.0950.5070.6140.664126.226.366.386.476.340.0580.7610.4000.430Haugh unit479.1681.1580.3380.2280.600.4470.7420.5520.678880.3583.9181.6781.4781.980.5960.4520.8510.7631280.2281.5081.5282.5081.230.5670.8240.4630.533an = 6 replicates per treatment (6 eggs per replicate). Table 4Effects of dietary marigold lutein supplementation on egg quality (excluding yolk color) of laying hensa.ItemPeriod (wk)Lutein supplementation level (mg/kg)SEMP-value04080120160ANOVALinearQuadraticEgg shape index41.321.321.321.321.320.0020.8920.3220.61781.311.321.341.331.350.0070.5980.1700.369121.311.321.321.331.320.0030.3070.0970.093Eggshell strength (N)440.2539.8539.6539.6139.940.3970.9890.7650.855834.7736.7336.6337.0536.990.5040.6160.1850.2981232.9532.7432.8633.3633.540.3050.9210.4100.651Eggshell thickness (μm)4409.53408.44410.89410.07410.640.7900.8910.5010.8018397.76395.60399.84402.40390.032.2130.4860.5900.43612398.99384.22402.70401.20400.062.6210.1540.3110.573Albumen height (mm)46.156.596.286.216.250.0570.1160.7100.50086.026.576.266.276.350.0950.5070.6140.664126.226.366.386.476.340.0580.7610.4000.430Haugh unit479.1681.1580.3380.2280.600.4470.7420.5520.678880.3583.9181.6781.4781.980.5960.4520.8510.7631280.2281.5081.5282.5081.230.5670.8240.4630.533an = 6 replicates per treatment (6 eggs per replicate). Effects of dietary marigold lutein supplementation on egg quality (excluding yolk color) of laying hensa. n = 6 replicates per treatment (6 eggs per replicate). Yolk color during lutein deposition and post-withdrawal clearance The effects of dietary marigold lutein supplementation on yolk color are presented in Table 5. During the deposition phase, yolk color score responded rapidly to dietary lutein supplementation. At D3, the 80, 120, and 160 mg/kg groups showed higher color scores than the control group, whereas the 40 mg/kg group was intermediate. Significant treatment, linear, and quadratic effects were observed at all sampling points from D3 to D28 (P < 0.001). The pigmentation response was maintained throughout supplementation, with D28 color scores of 6.83, 9.03, 9.60, 9.77, and 9.97 in hens fed 0, 40, 80, 120, and 160 mg/kg lutein, respectively. However, the 80, 120, and 160 mg/kg groups often shared superscripts, indicating an attenuated incremental response at higher supplementation levels.Table 5Effects of dietary marigold lutein supplementation on yolk color score of laying hens during lutein deposition and post-withdrawal clearancea.ItemTime pointbLutein supplementation level (mg/kg)SEMP-value04080120160ANOVALinearQuadraticDeposition phaseColor scoreD37.07b7.73ab7.93a8.30a8.30a0.111< 0.001< 0.001< 0.001D77.36c8.47b9.00ab9.13a9.47a0.147< 0.001< 0.001< 0.001D107.25b8.97a9.07a9.17a9.43a0.156< 0.001< 0.001< 0.001D147.18c8.90b9.18ab9.47a9.60a0.170< 0.001< 0.001< 0.001D217.16c8.91b9.50ab9.61a9.94a0.194< 0.001< 0.001< 0.001D286.83c9.03b9.60ab9.77a9.97a0.215< 0.001< 0.001< 0.001Post-withdrawal clearanceColor scoreWD05.53d7.50c8.58b9.97a9.51a0.343< 0.001< 0.001< 0.001WD35.83c6.80bc7.77b8.87a9.53a0.270< 0.001< 0.001< 0.001WD75.686.175.836.036.440.1090.2020.0690.178WD105.615.685.905.956.300.0960.1690.0120.041L* valueWD351.1648.9248.8349.4848.110.5160.4340.1320.279WD754.7954.0153.3254.1852.650.3480.3560.0950.254WD1054.3954.3454.3953.1953.930.4690.9270.5440.831a* valueWD31.36d2.63c3.33bc4.15ab5.13a0.263< 0.001< 0.001< 0.001WD71.642.152.182.272.370.0850.0550.0070.014WD101.77b1.86ab1.83ab1.86ab2.15a0.0430.0330.0100.013b* valueWD323.22b26.62ab28.23ab27.94ab29.29a0.6700.0300.0030.006WD723.7125.5326.3125.2624.410.5370.6180.7750.277WD1023.0223.4125.9826.7225.610.5850.1760.0380.070an = 6 replicates per treatment (6 eggs per replicate).bD3, D7, D10, D14, D21, and D28 indicate days 3, 7, 10, 14, 21, and 28 after the initiation of dietary lutein supplementation, respectively; WD0, WD3, WD7, and WD10 indicate days 0, 3, 7, and 10 after dietary lutein withdrawal, respectively.a-dWithin a row, means without a common superscript letter differ significantly (P < 0.05). Table 5Effects of dietary marigold lutein supplementation on yolk color score of laying hens during lutein deposition and post-withdrawal clearancea.ItemTime pointbLutein supplementation level (mg/kg)SEMP-value04080120160ANOVALinearQuadraticDeposition phaseColor scoreD37.07b7.73ab7.93a8.30a8.30a0.111< 0.001< 0.001< 0.001D77.36c8.47b9.00ab9.13a9.47a0.147< 0.001< 0.001< 0.001D107.25b8.97a9.07a9.17a9.43a0.156< 0.001< 0.001< 0.001D147.18c8.90b9.18ab9.47a9.60a0.170< 0.001< 0.001< 0.001D217.16c8.91b9.50ab9.61a9.94a0.194< 0.001< 0.001< 0.001D286.83c9.03b9.60ab9.77a9.97a0.215< 0.001< 0.001< 0.001Post-withdrawal clearanceColor scoreWD05.53d7.50c8.58b9.97a9.51a0.343< 0.001< 0.001< 0.001WD35.83c6.80bc7.77b8.87a9.53a0.270< 0.001< 0.001< 0.001WD75.686.175.836.036.440.1090.2020.0690.178WD105.615.685.905.956.300.0960.1690.0120.041L* valueWD351.1648.9248.8349.4848.110.5160.4340.1320.279WD754.7954.0153.3254.1852.650.3480.3560.0950.254WD1054.3954.3454.3953.1953.930.4690.9270.5440.831a* valueWD31.36d2.63c3.33bc4.15ab5.13a0.263< 0.001< 0.001< 0.001WD71.642.152.182.272.370.0850.0550.0070.014WD101.77b1.86ab1.83ab1.86ab2.15a0.0430.0330.0100.013b* valueWD323.22b26.62ab28.23ab27.94ab29.29a0.6700.0300.0030.006WD723.7125.5326.3125.2624.410.5370.6180.7750.277WD1023.0223.4125.9826.7225.610.5850.1760.0380.070an = 6 replicates per treatment (6 eggs per replicate).bD3, D7, D10, D14, D21, and D28 indicate days 3, 7, 10, 14, 21, and 28 after the initiation of dietary lutein supplementation, respectively; WD0, WD3, WD7, and WD10 indicate days 0, 3, 7, and 10 after dietary lutein withdrawal, respectively.a-dWithin a row, means without a common superscript letter differ significantly (P < 0.05). Effects of dietary marigold lutein supplementation on yolk color score of laying hens during lutein deposition and post-withdrawal clearancea. n = 6 replicates per treatment (6 eggs per replicate). D3, D7, D10, D14, D21, and D28 indicate days 3, 7, 10, 14, 21, and 28 after the initiation of dietary lutein supplementation, respectively; WD0, WD3, WD7, and WD10 indicate days 0, 3, 7, and 10 after dietary lutein withdrawal, respectively. a-dWithin a row, means without a common superscript letter differ significantly (P < 0.05). After lutein withdrawal, yolk color score remained affected by previous dietary treatment at WD0 and WD3 (P < 0.001). At WD0, color scores were 5.53, 7.50, 8.58, 9.97, and 9.51 in the 0, 40, 80, 120, and 160 mg/kg groups, respectively. Treatment differences persisted at WD3, but were no longer significant at WD7 or WD10 (P > 0.05). Nevertheless, significant linear and quadratic contrasts were still detected at WD10 (P = 0.012 and P = 0.041, respectively), suggesting a weak residual ordered response after withdrawal. Instrumental color measurements further supported the rapid attenuation of pigmentation after withdrawal. Previous lutein supplementation did not affect yolk lightness (L*) at WD3, WD7, or WD10 (P > 0.05). Redness (a*) remained more responsive: significant treatment, linear, and quadratic effects were observed at WD3 (P < 0.001), and a* still differed among treatments at WD10 (P = 0.033), with significant linear and quadratic responses (P = 0.010 and P = 0.013). Yolk yellowness (b*) was affected at WD3 (P = 0.030), with significant linear and quadratic responses (P = 0.003 and P = 0.006), but no significant overall treatment effect was detected at WD7 or WD10. Egg lutein content and incremental apparent deposition efficiency during supplementation Egg lutein content and incremental apparent deposition efficiency during lutein supplementation are presented in Table 6, Table 7, and Fig. 1. At D21, egg lutein content increased markedly with increasing dietary lutein supplementation, with significant treatment, linear, and quadratic effects (P < 0.001; Table 6). The 120 and 160 mg/kg groups had the highest values and did not differ significantly from each other, indicating an attenuated incremental enrichment response at the upper supplementation levels.Table 6Egg lutein content and incremental apparent deposition efficiency at D21a.ItembLutein supplementation level (mg/kg)SEMP-value04080120160ANOVALinearQuadraticEgg lutein content (μg/100 g EP)469.80d827.10c1001.48b1258.20a1364.40a87.329< 0.001< 0.001< 0.001Incremental apparent deposition efficiency (%)—8.42a6.22ab5.83b5.28b0.4280.0160.0030.006an = 6 replicates per treatment.bEP, edible portion. Incremental apparent deposition efficiency was calculated after correction for the mean daily egg lutein output of the control group. It was not calculated for the 0 mg/kg group because no supplemental lutein was provided.a-dWithin a row, means without a common superscript letter differ significantly (P < 0.05).Table 7Temporal changes in egg lutein content and incremental apparent deposition efficiency during supplementationa.ItembGroup (mg/kg)Lutein accumulation phase (days post-supplementation)SEMP-valueD3D7D10D14D21TimeGroupT × GEgg lutein content (μg/100 g EP)0457.43b439.65c457.43c399.38c469.80c20.080< 0.001< 0.001< 0.00140497.70ab722.70b762.08b771.08b827.10b120549.45a965.93a1019.93a1101.15a1258.20aIncremental apparent deposition efficiency (%)b0—————————402.47a6.73a7.18a8.74a8.42a0.484< 0.0010.0070.2471200.69b3.81b4.13b5.21b5.83ban = 6 replicates per treatment.bEP, edible portion. D3, D7, D10, D14, and D21 indicate days 3, 7, 10, 14, and 21 after the initiation of dietary lutein supplementation, respectively. Incremental apparent deposition efficiency was calculated relative to the time-matched control group and was not calculated for the 0 mg/kg group.a-cWithin a column, means without a common superscript letter differ significantly (P < 0.05).Fig. 1Temporal changes in egg lutein content and incremental apparent deposition efficiency during lutein supplementation. Bars (left axis) represent egg lutein content (μg/100 g edible portion, EP), and lines (right axis) represent incremental apparent deposition efficiency (%). The CON group (0 mg/kg) served as the time-matched background reference and was not assigned efficiency values because supplemental lutein intake was zero. D3, D7, D10, D14, and D21 denote days 3, 7, 10, 14, and 21 after the initiation of lutein supplementation, respectively. Data are presented as mean ± SEM (n = 6). Different letters above bars within the same time point indicate significant differences in egg lutein content among groups (P < 0.05). Table 6Egg lutein content and incremental apparent deposition efficiency at D21a.ItembLutein supplementation level (mg/kg)SEMP-value04080120160ANOVALinearQuadraticEgg lutein content (μg/100 g EP)469.80d827.10c1001.48b1258.20a1364.40a87.329< 0.001< 0.001< 0.001Incremental apparent deposition efficiency (%)—8.42a6.22ab5.83b5.28b0.4280.0160.0030.006an = 6 replicates per treatment.bEP, edible portion. Incremental apparent deposition efficiency was calculated after correction for the mean daily egg lutein output of the control group. It was not calculated for the 0 mg/kg group because no supplemental lutein was provided.a-dWithin a row, means without a common superscript letter differ significantly (P < 0.05). Egg lutein content and incremental apparent deposition efficiency at D21a. n = 6 replicates per treatment. EP, edible portion. Incremental apparent deposition efficiency was calculated after correction for the mean daily egg lutein output of the control group. It was not calculated for the 0 mg/kg group because no supplemental lutein was provided. a-dWithin a row, means without a common superscript letter differ significantly (P < 0.05). Table 7Temporal changes in egg lutein content and incremental apparent deposition efficiency during supplementationa.ItembGroup (mg/kg)Lutein accumulation phase (days post-supplementation)SEMP-valueD3D7D10D14D21TimeGroupT × GEgg lutein content (μg/100 g EP)0457.43b439.65c457.43c399.38c469.80c20.080< 0.001< 0.001< 0.00140497.70ab722.70b762.08b771.08b827.10b120549.45a965.93a1019.93a1101.15a1258.20aIncremental apparent deposition efficiency (%)b0—————————402.47a6.73a7.18a8.74a8.42a0.484< 0.0010.0070.2471200.69b3.81b4.13b5.21b5.83ban = 6 replicates per treatment.bEP, edible portion. D3, D7, D10, D14, and D21 indicate days 3, 7, 10, 14, and 21 after the initiation of dietary lutein supplementation, respectively. Incremental apparent deposition efficiency was calculated relative to the time-matched control group and was not calculated for the 0 mg/kg group.a-cWithin a column, means without a common superscript letter differ significantly (P < 0.05). Temporal changes in egg lutein content and incremental apparent deposition efficiency during supplementationa. n = 6 replicates per treatment. EP, edible portion. D3, D7, D10, D14, and D21 indicate days 3, 7, 10, 14, and 21 after the initiation of dietary lutein supplementation, respectively. Incremental apparent deposition efficiency was calculated relative to the time-matched control group and was not calculated for the 0 mg/kg group. a-cWithin a column, means without a common superscript letter differ significantly (P < 0.05). Temporal changes in egg lutein content and incremental apparent deposition efficiency during lutein supplementation. Bars (left axis) represent egg lutein content (μg/100 g edible portion, EP), and lines (right axis) represent incremental apparent deposition efficiency (%). The CON group (0 mg/kg) served as the time-matched background reference and was not assigned efficiency values because supplemental lutein intake was zero. D3, D7, D10, D14, and D21 denote days 3, 7, 10, 14, and 21 after the initiation of lutein supplementation, respectively. Data are presented as mean ± SEM (n = 6). Different letters above bars within the same time point indicate significant differences in egg lutein content among groups (P < 0.05). Incremental efficiency also differed among the four supplemented groups at D21 (P = 0.016), with significant linear and quadratic responses (P = 0.003 and P = 0.006, respectively). The efficiency was higher at 40 mg/kg than at 120 and 160 mg/kg, whereas the 80 mg/kg group was intermediate. Thus, increasing lutein supplementation produced greater egg lutein enrichment but less incremental deposition per unit of supplemental lutein. The temporal analysis showed that egg lutein content was affected by supplementation level, time, and their interaction (all P < 0.001; Table 7 and Fig. 1). Egg lutein content remained relatively stable in the control group but increased from 497.70 μg/100 g edible portion (EP) at D3 to 827.10 μg/100 g EP at D21 in the 40 mg/kg group and from 549.45 to 1,258.20 μg/100 g EP in the 120 mg/kg group. A treatment difference was detectable at D3, primarily between the control and 120 mg/kg groups, and all three groups differed from D7 onward (P < 0.05). Incremental efficiency increased overall during the 21-d period (P < 0.001) and was higher in the 40 mg/kg group than in the 120 mg/kg group (P = 0.007), with no supplementation level × time interaction (P = 0.247). It increased from 2.47% at D3 to 8.42% at D21 in the 40 mg/kg group and from 0.69% to 5.83% in the 120 mg/kg group. Post-withdrawal clearance of yolk lutein Egg lutein content and retention rate during the post-withdrawal clearance phase are presented in Table 8 and Fig. 2. Egg lutein content was significantly affected by withdrawal time, previous dietary treatment, and their interaction (P < 0.001). At WD0, egg lutein contents were 480.13, 718.47, and 1,452.53 μg/100 g EP in hens previously fed 0, 40, and 120 mg/kg lutein, respectively. Relative to D21, the mean egg lutein content at WD0 was higher in the 120 mg/kg group (1,452.53 vs. 1,258.20 μg/100 g EP) but lower in the 40 mg/kg group (718.47 vs. 827.10 μg/100 g EP). During the first 3 d after withdrawal, egg lutein content remained relatively stable in the supplemented groups, particularly in hens previously fed 120 mg/kg lutein, which maintained a value of 1,438.67 μg/100 g EP at WD3.Table 8Egg lutein content and retention rate during the post-withdrawal clearance phase in laying hens previously fed 0, 40, or 120 mg/kg dietary marigold luteina.ItembGroup (mg/kg)Post-withdrawal clearance phaseSEMP-valueWD0WD3WD7WD10TimeGroupT × GEgg lutein content (μg/100 g EP)0480.13c419.25c417.08b428.1332.510< 0.001< 0.001< 0.00140718.47b663.87b482.73ab373.531201452.53a1438.67a528.67a401.27Lutein retention rate (%)c0100.0086.9386.93a90.14a3.100< 0.001< 0.001< 0.00140100.0092.6567.24b51.99b120100.0099.2436.40c27.66can = 6 replicates per treatment.bEP, edible portion; WD0, WD3, WD7, and WD10 indicate days 0, 3, 7, and 10 after dietary lutein withdrawal, respectively. Baseline values (WD0) reflect egg lutein content at the end of the feeding trial and served as the reference for retention rate calculation.cLutein retention rate (%) = (egg lutein content at each post-withdrawal time point / egg lutein content at WD0) × 100. WD0 was set to 100.00% by definition for all groups.a-cWithin a column, means without a common superscript letter differ significantly (P < 0.05).Fig. 2Dynamic changes in egg lutein content and retention rate during the post-withdrawal phase in laying hens previously fed marigold lutein. Bars (left axis) represent egg lutein content (μg/100 g edible portion, EP); lines (right axis) represent lutein retention rate (%). WD0, WD3, WD7, and WD10 denote days 0, 3, 7, and 10 after dietary lutein withdrawal, respectively; WD0 represents egg lutein content at the end of the feeding trial and served as the reference point for retention rate calculation (set to 100% for all groups). Data are presented as mean ± SEM (n = 6). Different letters above bars within the same time point indicate significant differences among groups (P < 0.05). Table 8Egg lutein content and retention rate during the post-withdrawal clearance phase in laying hens previously fed 0, 40, or 120 mg/kg dietary marigold luteina.ItembGroup (mg/kg)Post-withdrawal clearance phaseSEMP-valueWD0WD3WD7WD10TimeGroupT × GEgg lutein content (μg/100 g EP)0480.13c419.25c417.08b428.1332.510< 0.001< 0.001< 0.00140718.47b663.87b482.73ab373.531201452.53a1438.67a528.67a401.27Lutein retention rate (%)c0100.0086.9386.93a90.14a3.100< 0.001< 0.001< 0.00140100.0092.6567.24b51.99b120100.0099.2436.40c27.66can = 6 replicates per treatment.bEP, edible portion; WD0, WD3, WD7, and WD10 indicate days 0, 3, 7, and 10 after dietary lutein withdrawal, respectively. Baseline values (WD0) reflect egg lutein content at the end of the feeding trial and served as the reference for retention rate calculation.cLutein retention rate (%) = (egg lutein content at each post-withdrawal time point / egg lutein content at WD0) × 100. WD0 was set to 100.00% by definition for all groups.a-cWithin a column, means without a common superscript letter differ significantly (P < 0.05). Egg lutein content and retention rate during the post-withdrawal clearance phase in laying hens previously fed 0, 40, or 120 mg/kg dietary marigold luteina. n = 6 replicates per treatment. EP, edible portion; WD0, WD3, WD7, and WD10 indicate days 0, 3, 7, and 10 after dietary lutein withdrawal, respectively. Baseline values (WD0) reflect egg lutein content at the end of the feeding trial and served as the reference for retention rate calculation. Lutein retention rate (%) = (egg lutein content at each post-withdrawal time point / egg lutein content at WD0) × 100. WD0 was set to 100.00% by definition for all groups. a-cWithin a column, means without a common superscript letter differ significantly (P < 0.05). Dynamic changes in egg lutein content and retention rate during the post-withdrawal phase in laying hens previously fed marigold lutein. Bars (left axis) represent egg lutein content (μg/100 g edible portion, EP); lines (right axis) represent lutein retention rate (%). WD0, WD3, WD7, and WD10 denote days 0, 3, 7, and 10 after dietary lutein withdrawal, respectively; WD0 represents egg lutein content at the end of the feeding trial and served as the reference point for retention rate calculation (set to 100% for all groups). Data are presented as mean ± SEM (n = 6). Different letters above bars within the same time point indicate significant differences among groups (P < 0.05). A pronounced decline occurred between WD3 and WD7. At WD7, egg lutein contents decreased to 417.08, 482.73, and 528.67 μg/100 g EP in the former 0, 40, and 120 mg/kg groups, respectively. The former 120 mg/kg group remained higher than the control group, whereas the former 40 mg/kg group was intermediate. By WD10, egg lutein contents had converged to 428.13, 373.53, and 401.27 μg/100 g EP, respectively, with no significant differences among groups. The retention-rate analysis showed the same rapid post-withdrawal decline. Significant effects of withdrawal time, previous dietary treatment, and their interaction were observed (P < 0.001). At WD3, hens previously fed 40 and 120 mg/kg lutein retained 92.65% and 99.24% of their respective WD0 egg lutein contents. By WD7, retention declined to 67.24% in the former 40 mg/kg group and 36.40% in the former 120 mg/kg group. At WD10, the corresponding retention rates further decreased to 51.99% and 27.66%. Retention values in the control group reflected background variation because no supplemental lutein had been provided. Overall, supplemental lutein-derived enrichment was largely maintained during the first 3 d after withdrawal but declined rapidly thereafter, with differences in absolute egg lutein content disappearing by WD10. Serum lipid-related indices, vitellogenin, and reproductive hormones The effects of 120 mg/kg dietary lutein supplementation on serum lipid-related indices, vitellogenin, and reproductive hormones are presented in Fig. 3. Compared with the control group, hens fed 120 mg/kg lutein had lower serum TC (P = 0.002), LDL-C (P = 0.031), VLDL (P = 0.007), and MTTP (P = 0.001). Serum TG was not significantly affected by lutein supplementation (P > 0.05), whereas HDL-C showed a nonsignificant increase in the LUT120 group (P = 0.061). These results indicate selective changes in circulating lipid-related indices rather than a uniform reduction in serum lipid classes. Serum VTG concentration was higher in the LUT120 group than in the control group (P = 0.002). Lutein supplementation also increased serum E2, LH, and FSH concentrations (P = 0.001, P = 0.001, and P = 0.002, respectively).Fig. 3Effects of dietary lutein supplementation on serum lipid metabolism parameters, vitellogenin, and reproductive hormones in laying hens. TC, total cholesterol; TG, triglycerides; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; VLDL, very low-density lipoprotein; VTG, vitellogenin; MTTP, microsomal triglyceride transfer protein; E2, estradiol; LH, luteinizing hormone; FSH, follicle-stimulating hormone. CON, basal diet without supplemental lutein; LUT120, lutein-supplemented diet (120 mg/kg). Data are presented as mean ± SEM (n = 6). Effects of dietary lutein supplementation on serum lipid metabolism parameters, vitellogenin, and reproductive hormones in laying hens. TC, total cholesterol; TG, triglycerides; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; VLDL, very low-density lipoprotein; VTG, vitellogenin; MTTP, microsomal triglyceride transfer protein; E2, estradiol; LH, luteinizing hormone; FSH, follicle-stimulating hormone. CON, basal diet without supplemental lutein; LUT120, lutein-supplemented diet (120 mg/kg). Data are presented as mean ± SEM (n = 6). Hepatic and ovarian gene expression The effects of 120 mg/kg dietary lutein supplementation on hepatic and ovarian mRNA expression are shown in Figs. 4A and B, respectively. In the liver, the LUT120 group showed lower relative mRNA abundance of BCO2 (P = 0.022), PPARγ (P = 0.020), and apoVLDL-II (P = 0.032), but higher expression of ERα (P = 0.002) and ApoA1 (P = 0.012), compared with the control group. Hepatic PPARα, MTTP, ERβ, and VTG-II expression did not differ significantly between groups (P > 0.05).Fig. 4Effects of dietary lutein supplementation on mRNA expression of genes in the liver and ovary of laying hens. (A) Hepatic gene expression: BCO2, beta-carotene oxygenase 2; PPARα, peroxisome proliferator-activated receptor alpha; PPARγ, peroxisome proliferator-activated receptor gamma; apoVLDL-II, apolipoprotein very low-density lipoprotein II; MTTP, microsomal triglyceride transfer protein; ERα, estrogen receptor alpha; ERβ, estrogen receptor beta; ApoA1, apolipoprotein A1; VTG-II, vitellogenin II. (B) Ovarian gene expression: VLDLR, very low-density lipoprotein receptor; SR-BI, scavenger receptor class B type I; CD36, cluster of differentiation 36; VTG-II, vitellogenin II; ApoA1, apolipoprotein A1; ERα, estrogen receptor alpha; ERβ, estrogen receptor beta. Data are presented as mean ± SEM (n = 6). Effects of dietary lutein supplementation on mRNA expression of genes in the liver and ovary of laying hens. (A) Hepatic gene expression: BCO2, beta-carotene oxygenase 2; PPARα, peroxisome proliferator-activated receptor alpha; PPARγ, peroxisome proliferator-activated receptor gamma; apoVLDL-II, apolipoprotein very low-density lipoprotein II; MTTP, microsomal triglyceride transfer protein; ERα, estrogen receptor alpha; ERβ, estrogen receptor beta; ApoA1, apolipoprotein A1; VTG-II, vitellogenin II. (B) Ovarian gene expression: VLDLR, very low-density lipoprotein receptor; SR-BI, scavenger receptor class B type I; CD36, cluster of differentiation 36; VTG-II, vitellogenin II; ApoA1, apolipoprotein A1; ERα, estrogen receptor alpha; ERβ, estrogen receptor beta. Data are presented as mean ± SEM (n = 6). In the ovary, 120 mg/kg lutein supplementation increased the relative mRNA abundance of VLDLR (P = 0.008), ApoA1 (P = 0.001), and ERα (P = 0.040), whereas SR-BI, CD36, VTG-II, and ERβ expression was not significantly affected (P > 0.05). These results indicate a selective transcriptional response involving hepatic carotenoid cleavage, apolipoprotein-related genes, estrogen signaling, and ovarian yolk-precursor uptake. Correlations between serum indices and hepatic or ovarian mRNA expression Pearson correlation analysis between selected serum indices and hepatic or ovarian mRNA expression is shown in Fig. 5. Across the 12 hens sampled from the control and LUT120 groups, serum E2 was positively correlated with ovarian ERα expression (r = 0.77, P = 0.0035) and ovarian ApoA1 expression (r = 0.86, P = 0.00039). Serum VTG was also positively correlated with ovarian VLDLR expression (r = 0.67, P = 0.018). In contrast, serum HDL-C was not significantly correlated with hepatic ApoA1 expression (r = 0.26, P = 0.42). These correlations suggest coordinated variation among serum endocrine or yolk-precursor indices and selected ovarian transcripts.Fig. 5Pearson correlation analysis between serum parameters and hepatic or ovarian gene mRNA expression in laying hens. (A) Correlation between serum E2 content and relative mRNA expression of ERα in the ovary; (B) correlation between serum E2 content and relative mRNA expression of ApoA1 in the ovary; (C) correlation between serum VTG content and relative mRNA expression of VLDLR in the ovary; (D) correlation between serum HDL-C content and relative mRNA expression of ApoA1 in the liver. Red dots represent the CON group (basal diet without supplemental lutein) and blue dots represent the LUT120 group (120 mg/kg lutein). The black solid line represents the Pearson linear regression line fitted across all individuals (n = 12), and the gray shaded area indicates the 95% confidence interval. r, Pearson correlation coefficient; *P < 0.05; **P < 0.01; ***P < 0.001; ns, not significant (P ≥ 0.05). Pearson correlation analysis between serum parameters and hepatic or ovarian gene mRNA expression in laying hens. (A) Correlation between serum E2 content and relative mRNA expression of ERα in the ovary; (B) correlation between serum E2 content and relative mRNA expression of ApoA1 in the ovary; (C) correlation between serum VTG content and relative mRNA expression of VLDLR in the ovary; (D) correlation between serum HDL-C content and relative mRNA expression of ApoA1 in the liver. Red dots represent the CON group (basal diet without supplemental lutein) and blue dots represent the LUT120 group (120 mg/kg lutein). The black solid line represents the Pearson linear regression line fitted across all individuals (n = 12), and the gray shaded area indicates the 95% confidence interval. r, Pearson correlation coefficient; *P < 0.05; **P < 0.01; ***P < 0.001; ns, not significant (P ≥ 0.05). Discussion The present study shows that dietary marigold-derived lutein effectively enriches egg yolk without compromising overall laying performance or conventional egg-quality traits. Yolk pigmentation responded rapidly to supplementation, and egg lutein content increased with both dietary dose and supplementation duration. Incremental apparent deposition efficiency, however, was lower at higher supplementation levels, even as egg lutein content increased. After withdrawal, supplemental lutein-derived enrichment was largely maintained for the first 3 d but declined sharply between WD3 and WD7, with treatment differences disappearing by WD10. In parallel, 120 mg/kg lutein altered serum lipid-related indices, reproductive hormones, vitellogenin, and selected hepatic and ovarian transcripts. Considered together, these differences were consistent with changes in hepatic carotenoid cleavage, circulating endocrine and lipid-related status, and ovarian yolk-precursor uptake. Dietary marigold-derived lutein did not significantly alter overall laying performance or conventional egg-quality traits during the 12-wk trial. Although HDEP showed a significant linear response during wk 9–12, the overall treatment effect in this period and the response across the full trial were not significant, indicating that this isolated contrast should not be interpreted as a sustained production benefit. This result is broadly consistent with previous studies showing that lutein or carotenoid supplementation primarily improves yolk pigmentation and carotenoid deposition rather than consistently enhancing laying performance (Chen et al., 2025b; Leeson et al., 2007; Malayoğlu et al., 2024). Differences among studies may partly reflect hen age, physiological status, carotenoid source, inclusion level, and supplementation duration; for example, productive responses appear more likely in aged or physiologically challenged birds than in young hens maintained under adequate conditions (Liu et al., 2023). Similarly, egg shape index, eggshell strength, eggshell thickness, albumen height, and Haugh unit were not affected by lutein supplementation, in agreement with previous reports that enhanced yolk pigmentation or lutein enrichment can occur without adverse effects on major physical egg-quality traits (Dansou et al., 2024; Miao et al., 2023; Wen et al., 2021). These findings indicate that marigold-derived lutein acted mainly as a yolk-enrichment ingredient, improving the visual and nutritional attributes of the yolk while preserving normal egg formation and internal quality. Yolk color responded rapidly to dietary lutein, with dose-related differences evident by D3 and maintained throughout the deposition phase. This finding agrees with the meta-analysis of Yunitasari et al. (2023), which identified yolk color as one of the most consistent responses to natural carotenoid supplementation in laying hens. Similar increases in yolk pigmentation have also been reported after supplementation with lutein or marigold-derived carotenoids (Dansou et al., 2024; Skřivan et al., 2015; Wen et al., 2021). In the present study, color scores generally increased with dietary inclusion, but the smaller differences among the 80-, 120-, and 160-mg/kg groups indicated diminishing visual returns at the upper levels. This pattern is consistent with the dependence of yolk pigmentation on dietary xanthophyll supply and deposition (Kljak et al., 2021b), as well as previous observations that high marigold inclusion does not necessarily produce proportional increases in yolk pigmentation (Sirri et al., 2007). Therefore, the attenuated color response at higher supplementation levels likely reflects both biological limits in visible pigmentation and the restricted resolution of visual scoring as yolk color intensifies, rather than complete cessation of lutein deposition. After withdrawal, yolk color score remained affected by previous dietary lutein level at WD0 and WD3, but treatment differences were no longer significant by WD7. Instrumental color measurements provided additional resolution during this clearance phase. Prior lutein supplementation had little effect on yolk lightness, whereas a* and b* retained dose-related responses at selected post-withdrawal time points, indicating that chromaticity indices were more sensitive than visual scores for detecting residual pigmentation. This distinction is important because yolk color intensity does not necessarily correspond directly to chemically measured carotenoid concentration; similar visual scores may occur even when lutein content differs (Kljak et al., 2021b). Thus, yolk color is useful for evaluating market appearance and pigment persistence, but direct lutein quantification remains necessary when the objective is to produce nutrient-enriched eggs with defined lutein content. Dietary marigold lutein produced a positive increase in egg lutein concentration. The significant linear response reflects greater substrate availability because increasing dietary inclusion provides more lutein for intestinal absorption, lipoprotein-mediated transport, and incorporation into developing follicles. As a fat-soluble xanthophyll, lutein is processed with dietary lipids and transported through circulating lipoprotein pathways to the ovary (Shi et al., 2023; Song et al., 2023). This interpretation agrees with Liu et al. (2023), who reported a linear increase in yolk lutein concentration with graded marigold-derived lutein. Leeson et al. (2007) similarly found that supplementation with 125 or 250 mg/kg lutein increased yolk pigmentation and egg lutein content, confirming that relatively high dietary inclusion can substantially enhance absolute enrichment. However, the concurrent quadratic response and the absence of a significant difference between the 120- and 160-mg/kg groups indicate attenuation of the incremental enrichment response at the upper inclusion levels. This pattern should not be interpreted as definitive physiological saturation, but it is consistent with diminishing marginal deposition, as also reported by Dansou et al. (2024). After correction for background egg lutein output, incremental apparent deposition efficiency declined from 8.42% at 40 mg/kg to 5.28% at 160 mg/kg, indicating less additional egg lutein deposition per unit of lutein supplied as supplementation increased. Similar declines in apparent deposition efficiency at higher carotenoid levels have been reported for lutein and related xanthophylls (Dansou et al., 2024; Kljak et al., 2021a; Leeson and Caston, 2004). This metric reflects several sequential processes, including lutein release from the feed matrix, micellization, intestinal bioaccessibility, systemic transport, and follicular incorporation. Lipid digestion and micelle formation influence lutein bioaccessibility (Dai et al., 2021), while feed-matrix characteristics, dietary oil, and emulsifier use can further modify carotenoid deposition in eggs (Zurak et al., 2024). The lower incremental efficiency at higher supplementation levels may therefore reflect cumulative constraints across absorption, transport, and ovarian deposition rather than limitation at a single step. Because lutein concentrations in the complete diets were not analytically confirmed, the calculated efficiencies should be interpreted as comparative estimates based on the formulated supplementation levels rather than absolute recovery of measured dietary lutein. From an application perspective, increasing supplementation raised egg lutein content but reduced the incremental return per unit of lutein supplied. The dynamic accumulation results further showed that lutein deposition depended on both supplementation duration and dietary level. Egg lutein content increased progressively during the first 21 d in hens fed 40 or 120 mg/kg lutein, with the 120 mg/kg group achieving greater absolute enrichment and the 40 mg/kg group maintaining higher incremental apparent deposition efficiency. Similar time-dependent increases in yolk carotenoids have been reported by Shin et al. (2016) and Wen et al. (2021). However, the time required to reach maximal enrichment appears to vary among studies. Ortiz et al. (2021) reported that total yolk xanthophyll concentration reached a maximum after 12 d of feeding biofortified orange corn and then remained stable. In the present study, egg lutein content continued to increase through D21, which may reflect differences in carotenoid source and composition, dietary level, hen age, basal carotenoid status, or diet formulation. This gradual increase is also consistent with hierarchical follicular development, because successively laid eggs originate from follicles exposed to the supplemented diet for progressively longer portions of yolk formation (Song et al., 2023). At WD0, after 12 wk of supplementation, egg lutein content was higher than at D21 in the 120 mg/kg group but lower in the 40 mg/kg group. Thus, the WD0 value descriptively suggests that accumulation may have continued beyond D21 at 120 mg/kg, but this pattern was not consistent across supplementation levels. Following withdrawal, egg lutein content remained comparatively high during the first 3 d but declined sharply between WD3 and WD7, with treatment differences disappearing by WD10. Similar post-withdrawal declines have been reported by Islam et al. (2017), Moreno et al. (2016), and Dansou et al. (2024), indicating that yolk carotenoid enrichment is rapidly lost once dietary supply is removed. The brief persistence after withdrawal likely reflects eggs derived from follicles that had already incorporated lutein before supplementation ceased. By contrast, the subsequent decline reflects eggs from follicles exposed to progressively less dietary lutein during yolk formation. This pattern has direct practical relevance: continuous dietary supplementation, or at least carefully timed feed-program transitions, is required to maintain consistent lutein enrichment in marketed eggs. Supplementation with 120 mg/kg lutein selectively altered serum lipid-related indices, reproductive hormones, and VTG. The decreases in TC, LDL-C, VLDL, and MTTP, together with unchanged TG, suggest selective remodeling of circulating lipid-related status rather than a general reduction in serum lipids. Previous studies have also shown that serum lipid responses to carotenoids vary with compound type, dose, duration, and physiological condition (Chen et al., 2025a; Gao et al., 2020). In the present study, the lower VLDL and MTTP values may reflect altered lipoprotein transport or turnover. In parallel, serum E2, FSH, LH, and VTG were increased by lutein supplementation. Because E2 stimulates hepatic yolk-precursor synthesis and VTG supplies material for follicular yolk deposition, their concurrent increases may have favored lutein delivery to the developing follicles (Cui et al., 2020; Song et al., 2023). Similar endocrine responses to marigold-derived lutein have been reported in aged breeder hens (Liu et al., 2023), although in the present study these changes were not accompanied by a consistent improvement in overall laying performance. The hepatic transcriptional response further supports selective regulation rather than broad activation of lipid and yolk-precursor synthesis. The reduction in hepatic BCO2 expression is particularly relevant because BCO2 oxidatively cleaves xanthophylls, and lower BCO2 expression may help preserve more intact lutein for systemic transport and yolk deposition (dela Seña et al., 2016; Miao et al., 2023). Lutein also increased hepatic ERα and ApoA1 expression, suggesting enhanced estrogen responsiveness and altered apolipoprotein-related lipid handling. However, the reduced apoVLDL-II expression and unchanged VTG-II and MTTP expression indicate that classical hepatic yolk-precursor and VLDL-assembly genes were not uniformly activated at the sampling time. Therefore, the hepatic response appears to involve reduced carotenoid cleavage and selective adjustment of estrogen- and apolipoprotein-related transcripts, rather than generalized stimulation of hepatic vitellogenesis or lipid export. At the ovarian level, the increased expression of VLDLR, ApoA1, and ERα provides a plausible transcriptional link between circulating yolk precursors and enhanced lutein deposition. VLDLR is the principal receptor mediating oocyte uptake of VLDL and VTG during yolk formation, and its upregulation is consistent with greater ovarian capacity for yolk-precursor uptake (Barber et al., 1991; Bujo et al., 1994; Chen et al., 2020). Increased ovarian ApoA1 and ERα expression further suggests local adjustment of lipoprotein handling and estrogen responsiveness. In contrast, SR-BI, CD36, VTG-II, and ERβ were unchanged, indicating that the ovarian response was selective rather than a broad activation of all lipid-uptake or estrogen-signaling genes. The pooled correlation analysis supported this interpretation, as serum E2 was positively correlated with ovarian ERα and ApoA1 expression, and serum VTG was positively correlated with ovarian VLDLR expression. It should be noted that the serum, transcriptional, and correlation analyses were based on 6 hens per group and involved multiple comparisons without adjustment; accordingly, the reported P values are nominal and the findings should be interpreted as exploratory. Moreover, because these measurements were limited to the control and 120 mg/kg groups, whether the observed responses vary with dietary dose remains undetermined. Within this comparison, lower hepatic BCO2 expression may help preserve lutein for systemic transport, while changes in circulating endocrine and lipid-related indices and higher ovarian expression of genes related to yolk-precursor uptake may favor its delivery to and deposition in developing follicles. Conclusion Dietary marigold-derived lutein effectively enriched egg yolk without adversely affecting overall laying performance or conventional egg quality. Egg lutein content increased with dietary inclusion and supplementation duration, whereas incremental apparent deposition efficiency declined at higher levels, showing that greater enrichment was accompanied by a smaller incremental return per unit of lutein supplied. After withdrawal, lutein enrichment declined rapidly after the first 3 d and treatment differences disappeared by WD10, suggesting that continuous supplementation is needed to maintain consistent lutein-enriched egg production. Serum and transcriptional differences between the control and 120 mg/kg groups were consistent with changes in hepatic carotenoid cleavage, endocrine and lipid-related status, and ovarian yolk-precursor transport. These exploratory findings provide physiological context for lutein deposition but do not establish a dose-dependent mechanism. Overall, marigold lutein can be used as an effective yolk-enrichment strategy, with inclusion level selected according to the desired balance between lutein content and deposition efficiency. Authorship contributions Shan Gao conducted the feeding trial, recorded laying performance, collected samples, performed egg-quality measurements, and analyzed the experimental data. Uchechukwu Edna Obianwuna analyzed and interpreted the lutein accumulation and withdrawal data and prepared the initial draft of the manuscript. Wenke Tao conducted the animal experiment, collected egg and tissue samples, and participated in the laboratory measurements. Kai Qiu performed the lutein measurements and analyzed the lutein accumulation, deposition-efficiency, and post-withdrawal data. Jing Wang contributed to the design of the dose-response and withdrawal components and interpretation of the temporal response patterns. Haijun Zhang guided the analyses of the principal biochemical and molecular indices and was responsible for the statistical analysis and interpretation of these data. Guanghai Qi contributed to the experimental design and interpretation of the nutritional and physiological significance of the results. Jianmin Zhou conceived and designed the study, integrated and interpreted the egg lutein, serum, and gene-expression data, and led preparation of the manuscript. Shugeng Wu helped formulate the research question and dietary treatment design and interpreted the principal findings of the study. All authors approved the final version of the manuscript and accept responsibility for the accuracy and integrity of the work. Disclosures The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.